BIO Bio-Rad Laboratories, Inc. Stock Quote

BIO [NYSE]

Index	S&P 500	P/E	4.39	EPS (ttm)	135.93	Insider Own	3.20%	Shs Outstand	29.82M	Perf Week	-0.29%
Market Cap	17.73B	Forward P/E	47.43	EPS next Y	12.57	Insider Trans	-0.14%	Shs Float	21.37M	Perf Month	-1.26%
Income	4.10B	PEG	0.25	EPS next Q	3.00	Inst Own	81.20%	Short Float	2.68%	Perf Quarter	-6.30%
Sales	2.70B	P/S	6.56	EPS this Y	116.60%	Inst Trans	-0.36%	Short Ratio	3.21	Perf Half Y	-7.32%
Book/sh	355.73	P/B	1.68	EPS next Y	1.28%	ROA	33.40%	Target Price	755.00	Perf Year	26.79%
Cash/sh	34.31	P/C	17.38	EPS next 5Y	17.80%	ROE	44.70%	52W Range	425.43 - 689.00	Perf YTD	2.31%
Dividend	-	P/FCF	33.50	EPS past 5Y	101.00%	ROI	-6.90%	52W High	-14.97%	Beta	0.83
Dividend %	-	Quick Ratio	2.60	Sales past 5Y	4.70%	Gross Margin	56.30%	52W Low	37.71%	ATR	15.23
Employees	8000	Current Ratio	3.60	Sales Q/Q	27.20%	Oper. Margin	16.40%	RSI (14)	37.03	Volatility	2.06% 2.38%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	42.50%	Profit Margin	-	Rel Volume	0.34	Prev Close	596.38
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Apr 29 AMC	Payout	0.00%	Avg Volume	178.30K	Price	585.85
Recom	1.50	SMA20	-6.05%	SMA50	-1.35%	SMA200	2.91%	Volume	41,665	Change	-1.77%

Jan-08-20

Initiated

Wells Fargo

Overweight

$430

Jan-07-20

Initiated

Citigroup

Buy

$450

Oct-17-18

Initiated

Goldman

Buy

$350

Sep-20-18

Initiated

Morgan Stanley

Equal-Weight

$335

Feb-16-18

Downgrade

CL King

Buy → Neutral

Jul-13-17

Initiated

Wells Fargo

Outperform

Jun-28-17

Upgrade

Deutsche Bank

Hold → Buy

$220 → $255

Jan-18-17

Initiated

Deutsche Bank

Hold

$195

Oct-13-16

Initiated

CL King

Buy

May-06-15

Reiterated

Jefferies

Buy

$150 → $165

Dec-18-09

Initiated

Maxim Group

Buy

$125

Nov-06-09

Initiated

Jefferies & Co

Buy

$130

Jul-17-09

Initiated

Soleil

Buy

$91

Sep-26-07

Initiated

Banc of America Sec

Buy

$110

Feb-23-07

Downgrade

Robert W. Baird

Outperform → Neutral

$83 → $76

May-10-21 05:13PM	Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)? Insider Monkey
11:11AM	Why I Relish Low-Debt Stocks GuruFocus.com
May-01-21 10:17AM	Top Stocks for May 2021 Investopedia
Apr-30-21 09:29AM	Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Guidance Up Zacks
05:31AM	Bio-Rad Laboratories Inc (BIO) Q1 2021 Earnings Call Transcript Motley Fool
02:19AM	Is It Too Late To Consider Buying Bio-Rad Laboratories, Inc. (NYSE:BIO)? Simply Wall St.
Apr-29-21 05:45PM	Bio-Rad Laboratories (BIO) Q1 Earnings and Revenues Beat Estimates Zacks
04:15PM	Bio-Rad Reports First-Quarter 2021 Financial Results Business Wire
Apr-28-21 05:32PM	What Investors Need to Know About 10x Genomics Motley Fool
Apr-26-21 08:09AM	BioRad (BIO) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-22-21 04:49PM	Top Healthcare Stocks for May 2021 Investopedia
12:33PM	Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Apr-15-21 08:30AM	Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021 Business Wire
Apr-13-21 09:36AM	Thermo Fisher (TMO) Rides on End Markets as Pandemic Rages On Zacks
Apr-05-21 08:37AM	Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day Zacks
Apr-01-21 09:18AM	COVID-19 Resurgence Accelerates Diagnostic Testing: 3 Top Picks Zacks
Mar-29-21 03:44PM	Is Bio-Rad (BIO) Stock A Buy or Sell? Insider Monkey
Mar-26-21 12:24PM	Analysts See Plenty of Potential for 10x Genomics GuruFocus.com
08:16AM	The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Cardinal Health, Abbott Lab, Hologic and Bio-Rad Lab Zacks
Mar-22-21 06:18PM	3 Health Care Stocks Trading Below Graham's Valuation GuruFocus.com
Mar-15-21 07:31AM	Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Zacks
Mar-13-21 11:30AM	Why Is Bio-Rad (BIO) Down 13% Since Last Earnings Report? Zacks
Mar-11-21 10:45AM	3 High-Quality Picks for the Value Investor GuruFocus.com
Mar-05-21 04:16PM	Bio-Rad to Participate in Barclays Global Healthcare Conference 2021 Business Wire
Feb-22-21 04:15PM	Bio-Rad to Participate in Citis 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Business Wire -5.25%
Feb-12-21 09:19AM	Bio-Rad (BIO) Q4 Earnings Surpass Estimates, Margins Rise Zacks
05:31AM	Bio-Rad Laboratories Inc (BIO) Q4 2020 Earnings Call Transcript Motley Fool
05:29AM	Bio-Rad 4Q Sales Top Estimates Driven By COVID-19 Demand SmarterAnalyst
Feb-11-21 05:45PM	Bio-Rad Laboratories (BIO) Q4 Earnings and Revenues Surpass Estimates Zacks
04:52PM	Bio-Rad Laboratories: Q4 Earnings Insights Benzinga
04:20PM	Bio-Rad Reports Fourth-Quarter and Full-Year 2020 Financial Results Business Wire
Feb-10-21 10:30AM	Earnings Preview: Bio-Rad Laboratories Benzinga
09:12AM	Medical Products' Feb 11 Earnings Roster: DXCM, LH & More Zacks
Feb-08-21 09:51AM	A Look Into Healthcare Sector Value Stocks Benzinga
Feb-05-21 09:53AM	Bio-Rad (BIO) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-04-21 04:10PM	10 Cheap Healthcare Stocks To Buy Now Insider Monkey
Jan-25-21 04:15PM	Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021 Business Wire
Jan-21-21 08:00AM	Bio-Rad's CEO Just Shared His Four-Part Plan For Success Investor's Business Daily
Jan-10-21 10:51AM	A Trio of High Earnings Return Stocks GuruFocus.com
Jan-08-21 08:30AM	Bio-Rad to Participate in Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on January 11 Business Wire
Dec-21-20 01:20PM	Bio Rad Labs Sees Composite Rating Improve To 96 Investor's Business Daily
09:54AM	A Look Into Healthcare Sector Value Stocks Benzinga
Dec-14-20 07:17PM	Is BIO A Good Stock To Buy Now? Insider Monkey
Dec-11-20 08:11AM	The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street Benzinga
Dec-10-20 05:33PM	Bio-Rad Provides Outlook Through 2023 Business Wire
Dec-04-20 08:45AM	Cooper Companies (COO) Q4 Earnings & Revenues Top Estimates Zacks
Dec-02-20 11:08AM	Patterson Companies (PDCO) Q2 Earnings Top Estimates, Up Y/Y Zacks
Nov-27-20 09:21AM	Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Zacks
Nov-19-20 11:30AM	Is BioRad Laboratories (BIO) Outperforming Other Medical Stocks This Year? Zacks
Nov-13-20 09:08AM	Top Ranked Momentum Stocks to Buy for November 13th Zacks
Nov-11-20 12:19PM	A Trio of Potential Deals You Shouldn't Miss GuruFocus.com +5.34%
Nov-09-20 10:39AM	Bio-Rad Laboratories' (BIO) Shares March Higher, Can It Continue? Zacks -9.87%
Nov-04-20 12:20PM	Can Bio-Rad (BIO) Run Higher on Rising Earnings Estimates? Zacks
Oct-30-20 10:45AM	Bio-Rad (BIO) Q3 Earnings Surpass Estimates, Margins Rise Zacks
04:31AM	Bio-Rad Laboratories Inc (BIO) Q3 2020 Earnings Call Transcript Motley Fool
Oct-29-20 05:45PM	Bio-Rad Laboratories (BIO) Q3 Earnings and Revenues Top Estimates Zacks
04:59PM	Bio-Rad Laboratories: Q3 Earnings Insights Benzinga
04:15PM	Bio-Rad Reports Third-Quarter 2020 Financial Results Business Wire
Oct-28-20 04:36PM	MediaAlpha Stock Rockets 64% as Root Insurance and Other IPOs Fall Flat Barrons.com -5.10%
12:41PM	MediaAlpha and Biodesix Stock Will Make Their Trading Debuts Today Barrons.com
09:53AM	Medical Products' Oct 29 Earnings Roster: SYK, BAX & More Zacks
Oct-26-20 12:25PM	Was The Smart Money Right About Crowding Into Bio-Rad Laboratories, Inc. (BIO)? Insider Monkey
Oct-24-20 08:35AM	Bio-Rad Laboratories (NYSE:BIO) Seems To Use Debt Rather Sparingly Simply Wall St.
Oct-23-20 08:44AM	Bio-Rad (BIO) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-22-20 12:33PM	Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-19-20 08:30AM	Bio-Rad to Report Third-Quarter 2020 Financial Results, Thursday, October 29, 2020 Business Wire
Oct-12-20 02:53PM	5 stocks for the next 10 years some picks are obvious, others not so much MarketWatch
09:53AM	Bio-Rad (BIO) Hits a New 52-Week High: What's Driving It? Zacks
Sep-25-20 01:52PM	3 Health Care Companies to Consider as Covid-19 Vaccine Trials Continue GuruFocus.com
Sep-21-20 09:56AM	A Look Into Healthcare Sector Value Stocks Benzinga
Sep-14-20 09:46AM	A Look Into Healthcare Sector Value Stocks Benzinga
Sep-02-20 07:47AM	The Bio-Rad Laboratories (NYSE:BIO) Share Price Has Gained 267%, So Why Not Pay It Some Attention? Simply Wall St.
Aug-31-20 12:54PM	Hedge Funds Never Been This Bullish On Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
Aug-29-20 11:31AM	Bio-Rad (BIO) Down 6.9% Since Last Earnings Report: Can It Rebound? Zacks
Aug-24-20 11:35AM	A Look Into Healthcare Sector Value Stocks Benzinga
Aug-17-20 11:46AM	5 Value Stocks To Watch In The Healthcare Sector Benzinga
Aug-10-20 08:31AM	Why Bio-Rad Laboratories (BIO) Could Be Positioned for a Surge Zacks
Aug-07-20 12:20PM	Will Bio-Rad (BIO) Gain on Rising Earnings Estimates? Zacks
10:23AM	Are Robust Financials Driving The Recent Rally In Bio-Rad Laboratories, Inc.'s (NYSE:BIO) Stock? Simply Wall St.
Aug-04-20 08:30AM	The United States Court of Appeals for the Federal Circuit Affirms That 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Courts Award of Damages Business Wire
Jul-31-20 08:33PM	Bio-Rad Laboratories Inc (BIO) (BIO.B) Q2 2020 Earnings Call Transcript Motley Fool
10:36AM	Bio-Rad (BIO) Q2 Earnings Beat Estimates, Gross Margin Rises Zacks
Jul-30-20 05:45PM	Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Surpass Estimates Zacks
04:15PM	Bio-Rad Reports Second-Quarter 2020 Financial Results Business Wire
Jul-29-20 09:16AM	Medical Products Stock Earnings on Jul 30: BAX, SYK & More Zacks
Jul-27-20 08:29AM	Bio-Rad (BIO) to Report Q2 Earnings: What's in the Offing? Zacks
Jul-24-20 07:31PM	Earnings Season Watch List: Bio Rad Labs Hits New Highs Investor's Business Daily
Jul-23-20 12:32PM	Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-15-20 08:01PM	Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020 Business Wire
Jul-13-20 08:12PM	Did Hedge Funds Make The Right Call On Bio-Rad Laboratories, Inc. (BIO) ? Insider Monkey
Jul-09-20 03:57PM	Biomarin's Hemophilia A Drug Among 5 Up for FDA Approval Soon GuruFocus.com
09:32AM	Bio-Rad (BIO) Banks on Coronavirus PCR Tests Amid Cost Woes Zacks
Jun-30-20 05:18PM	3 Health Care Companies That Beat the Market in the 1st Half of the Year GuruFocus.com
10:40AM	Bio-Rad Rides on PCR Test Kits for Coronavirus Amid Cost Woe Zacks
Jun-15-20 11:31AM	T. Rowe Price and Align Technology Show High Profit, Low Debt GuruFocus.com
Jun-12-20 06:18PM	S&P Dow Jones Indices Announces Tyler Technologies, Bio-Rad Laboratories and Teledyne Technologies Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire
Jun-11-20 07:30PM	RPT-Outbreak quashed, China launches test lab spending spree Reuters -6.44%
06:00AM	Outbreak quashed, China launches test lab spending spree Reuters
Jun-08-20 10:22AM	Bio-Rad Rides on New Coronavirus Tests Amid Cost Concerns Zacks
Jun-05-20 10:00AM	Why Coronavirus Testing Stocks Are Among 4 Key Health Care Stocks Investor's Business Daily

Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RAMALINGAM AJIT	SVP, Chief Accounting Officer	Apr 29	Option Exercise	0.00	276	0	318	May 03 01:48 PM
Last Andrew J.	EVP, Chief Operating Officer	Apr 29	Option Exercise	0.00	1,000	0	1,734	Apr 30 02:31 PM
Daskal Ilan	EVP, Chief Financial Officer	Apr 08	Option Exercise	0.00	700	0	1,157	Apr 09 11:38 AM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Feb 19	Option Exercise	159.32	400	63,728	2,143	Feb 22 04:05 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Feb 19	Sale	640.77	923	591,499	1,220	Feb 22 04:05 PM
WRIGHT DARA	Executive Vice President	Dec 16	Option Exercise	0.00	502	0	502	Dec 17 04:34 PM
Crowley Michael	EVP, GBL Commercial Operations	Dec 15	Sale	580.67	374	217,171	3,669	Dec 17 12:54 PM
TUMOLO ANNETTE	Executive Vice President	Nov 06	Option Exercise	159.32	1,200	191,184	5,322	Nov 10 12:40 PM
TUMOLO ANNETTE	Executive Vice President	Nov 06	Sale	640.72	1,200	768,865	4,122	Nov 10 12:40 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 11	Option Exercise	0.00	3,200	0	299,834	Sep 15 02:13 PM
HUTTON RONALD W	Vice President and Treasurer	Sep 11	Option Exercise	0.00	150	0	4,740	Sep 14 06:59 PM
TUMOLO ANNETTE	Executive Vice President	Sep 11	Option Exercise	0.00	600	0	4,420	Sep 14 06:55 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 11	Option Exercise	0.00	600	0	4,341	Sep 14 06:50 PM
Magni Giovanni	EVP, Chief Strategy Officer	Sep 11	Option Exercise	69.78	1,000	69,780	22,743	Sep 14 11:42 AM
Magni Giovanni	EVP, Chief Strategy Officer	Sep 10	Option Exercise	259.11	1,771	458,882	22,410	Sep 14 11:42 AM
Magni Giovanni	EVP, Chief Strategy Officer	Sep 08	Option Exercise	0.00	400	0	21,829	Sep 09 01:48 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 07	Option Exercise	0.00	3,000	0	298,122	Sep 09 02:53 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 07	Option Exercise	0.00	500	0	1,960	Sep 09 02:00 PM
HUTTON RONALD W	Vice President and Treasurer	Sep 07	Option Exercise	0.00	170	0	4,649	Sep 09 01:57 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 07	Option Exercise	0.00	600	0	4,039	Sep 09 01:56 PM
TUMOLO ANNETTE	Executive Vice President	Sep 07	Option Exercise	0.00	600	0	4,118	Sep 09 01:44 PM
TUMOLO ANNETTE	Executive Vice President	Sep 05	Option Exercise	0.00	600	0	3,765	Sep 09 01:44 PM
Magni Giovanni	EVP, Chief Strategy Officer	Sep 05	Option Exercise	0.00	500	0	21,677	Sep 09 01:46 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 05	Option Exercise	0.00	600	0	3,665	Sep 09 01:56 PM
HUTTON RONALD W	Vice President and Treasurer	Sep 05	Option Exercise	0.00	180	0	4,542	Sep 09 01:57 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 05	Option Exercise	0.00	500	0	1,633	Sep 09 02:00 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 05	Option Exercise	0.00	2,600	0	420,261	Sep 09 02:53 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 04	Option Exercise	0.00	2,600	0	418,951	Sep 09 02:53 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 04	Option Exercise	0.00	500	0	1,306	Sep 09 02:00 PM
HUTTON RONALD W	Vice President and Treasurer	Sep 04	Option Exercise	0.00	180	0	4,425	Sep 09 01:57 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 04	Option Exercise	0.00	600	0	3,273	Sep 09 01:56 PM
Magni Giovanni	EVP, Chief Strategy Officer	Sep 04	Option Exercise	0.00	500	0	21,425	Sep 09 01:46 PM
TUMOLO ANNETTE	Executive Vice President	Sep 04	Option Exercise	0.00	600	0	3,373	Sep 09 01:44 PM
SCHWARTZ NORMAN D	Chairman, President and CEO	Sep 03	Option Exercise	0.00	2,319	0	417,501	Sep 08 03:20 PM
TUMOLO ANNETTE	Executive Vice President	Sep 03	Option Exercise	0.00	556	0	2,966	Sep 08 01:00 PM
Magni Giovanni	EVP, Chief Strategy Officer	Sep 03	Option Exercise	0.00	371	0	21,109	Sep 08 12:51 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 03	Option Exercise	0.00	464	0	967	Sep 08 01:09 PM
HUTTON RONALD W	Vice President and Treasurer	Sep 03	Option Exercise	0.00	154	0	4,299	Sep 08 12:43 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 03	Option Exercise	0.00	556	0	2,866	Sep 08 12:32 PM
Magni Giovanni	EVP, Chief Strategy Officer	Aug 19	Option Exercise	121.59	21,150	2,571,564	33,585	Aug 21 02:01 PM
Magni Giovanni	EVP, Chief Strategy Officer	Aug 19	Sale	519.88	12,847	6,678,844	20,738	Aug 21 02:01 PM
Magni Giovanni	EVP, Chief Strategy Officer	Aug 18	Sale	518.81	2,382	1,235,805	12,435	Aug 19 12:42 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Jun 12	Option Exercise	84.57	37,000	3,129,090	316,982	Jun 15 07:02 PM
Crowley Michael	EVP, GBL Commercial Operations	Jun 01	Sale	485.40	1,500	728,100	2,310	Jun 02 05:11 PM
HUTTON RONALD W	Vice President and Treasurer	May 13	Sale	457.35	443	202,606	4,140	May 14 01:11 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience